vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and Proto Labs Inc (PRLB). Click either name above to swap in a different company.

COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $136.5M, roughly 1.1× Proto Labs Inc). On growth, Proto Labs Inc posted the faster year-over-year revenue change (12.1% vs 2.9%). Proto Labs Inc produced more free cash flow last quarter ($8.4M vs $-126.4M). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs 3.3%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

Protolabs is a company that provides rapid manufacturing of 3D printed, CNC-machined, sheet metal, and injection-molded custom parts for prototyping and production. Markets like medical devices, aerospace, electronics, appliances, automotive and consumer products use these parts. Protolabs' headquarters are located in Maple Plain, Minnesota, with Minnesota-based manufacturing facilities in Plymouth, Brooklyn Park, and Rosemount, along with additional facilities in Nashua, New Hampshire and Ca...

CNS vs PRLB — Head-to-Head

Bigger by revenue
CNS
CNS
1.1× larger
CNS
$143.8M
$136.5M
PRLB
Growing faster (revenue YoY)
PRLB
PRLB
+9.2% gap
PRLB
12.1%
2.9%
CNS
More free cash flow
PRLB
PRLB
$134.8M more FCF
PRLB
$8.4M
$-126.4M
CNS
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
3.3%
PRLB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
PRLB
PRLB
Revenue
$143.8M
$136.5M
Net Profit
$34.9M
Gross Margin
44.2%
Operating Margin
28.0%
5.0%
Net Margin
24.3%
Revenue YoY
2.9%
12.1%
Net Profit YoY
-23.9%
EPS (diluted)
$0.67
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
PRLB
PRLB
Q4 25
$143.8M
$136.5M
Q3 25
$141.7M
$135.4M
Q2 25
$136.1M
$135.1M
Q1 25
$134.5M
$126.2M
Q4 24
$139.8M
$121.8M
Q3 24
$133.2M
$125.6M
Q2 24
$121.7M
$125.6M
Q1 24
$122.7M
$127.9M
Net Profit
CNS
CNS
PRLB
PRLB
Q4 25
$34.9M
Q3 25
$41.7M
$7.2M
Q2 25
$36.8M
$4.4M
Q1 25
$39.8M
$3.6M
Q4 24
$45.8M
Q3 24
$39.7M
$7.2M
Q2 24
$31.8M
$4.5M
Q1 24
$34.0M
$5.3M
Gross Margin
CNS
CNS
PRLB
PRLB
Q4 25
44.2%
Q3 25
45.3%
Q2 25
44.3%
Q1 25
44.1%
Q4 24
42.7%
Q3 24
45.6%
Q2 24
45.0%
Q1 24
44.9%
Operating Margin
CNS
CNS
PRLB
PRLB
Q4 25
28.0%
5.0%
Q3 25
34.5%
6.5%
Q2 25
31.8%
3.7%
Q1 25
33.6%
3.6%
Q4 24
35.3%
-1.2%
Q3 24
33.7%
6.8%
Q2 24
31.5%
4.8%
Q1 24
32.8%
5.3%
Net Margin
CNS
CNS
PRLB
PRLB
Q4 25
24.3%
Q3 25
29.4%
5.3%
Q2 25
27.1%
3.3%
Q1 25
29.6%
2.9%
Q4 24
32.8%
Q3 24
29.8%
5.7%
Q2 24
26.1%
3.6%
Q1 24
27.7%
4.1%
EPS (diluted)
CNS
CNS
PRLB
PRLB
Q4 25
$0.67
$0.25
Q3 25
$0.81
$0.30
Q2 25
$0.72
$0.18
Q1 25
$0.77
$0.15
Q4 24
$0.89
$-0.01
Q3 24
$0.77
$0.29
Q2 24
$0.63
$0.18
Q1 24
$0.68
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
PRLB
PRLB
Cash + ST InvestmentsLiquidity on hand
$145.5M
$128.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$562.0M
$673.9M
Total Assets
$876.7M
$763.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
PRLB
PRLB
Q4 25
$145.5M
$128.1M
Q3 25
$98.1M
$119.2M
Q2 25
$95.4M
$103.2M
Q1 25
$65.2M
$96.8M
Q4 24
$183.0M
$103.1M
Q3 24
$106.5M
$100.5M
Q2 24
$122.0M
$112.9M
Q1 24
$99.5M
$109.7M
Stockholders' Equity
CNS
CNS
PRLB
PRLB
Q4 25
$562.0M
$673.9M
Q3 25
$550.3M
$664.7M
Q2 25
$528.5M
$664.7M
Q1 25
$507.7M
$656.8M
Q4 24
$511.7M
$670.2M
Q3 24
$491.0M
$680.0M
Q2 24
$463.2M
$685.2M
Q1 24
$378.9M
$687.3M
Total Assets
CNS
CNS
PRLB
PRLB
Q4 25
$876.7M
$763.4M
Q3 25
$801.6M
$756.9M
Q2 25
$751.0M
$743.3M
Q1 25
$834.9M
$737.5M
Q4 24
$812.4M
$743.5M
Q3 24
$727.8M
$753.8M
Q2 24
$784.1M
$758.2M
Q1 24
$680.7M
$769.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
PRLB
PRLB
Operating Cash FlowLast quarter
$-120.4M
$16.5M
Free Cash FlowOCF − Capex
$-126.4M
$8.4M
FCF MarginFCF / Revenue
-87.9%
6.2%
Capex IntensityCapex / Revenue
4.2%
5.9%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$59.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
PRLB
PRLB
Q4 25
$-120.4M
$16.5M
Q3 25
$55.1M
$29.1M
Q2 25
$-67.6M
$10.6M
Q1 25
$-108.9M
$18.4M
Q4 24
$96.7M
$17.3M
Q3 24
$25.6M
$24.8M
Q2 24
$31.4M
$14.4M
Q1 24
$4.9M
$21.3M
Free Cash Flow
CNS
CNS
PRLB
PRLB
Q4 25
$-126.4M
$8.4M
Q3 25
$52.6M
$25.0M
Q2 25
$-69.8M
$9.1M
Q1 25
$-110.0M
$17.1M
Q4 24
$85.0M
$16.5M
Q3 24
$24.2M
$23.2M
Q2 24
$27.1M
$10.2M
Q1 24
$537.0K
$18.8M
FCF Margin
CNS
CNS
PRLB
PRLB
Q4 25
-87.9%
6.2%
Q3 25
37.1%
18.5%
Q2 25
-51.3%
6.7%
Q1 25
-81.8%
13.6%
Q4 24
60.8%
13.5%
Q3 24
18.2%
18.5%
Q2 24
22.3%
8.2%
Q1 24
0.4%
14.7%
Capex Intensity
CNS
CNS
PRLB
PRLB
Q4 25
4.2%
5.9%
Q3 25
1.8%
3.0%
Q2 25
1.6%
1.1%
Q1 25
0.8%
1.0%
Q4 24
8.3%
0.7%
Q3 24
1.1%
1.2%
Q2 24
3.5%
3.3%
Q1 24
3.5%
2.0%
Cash Conversion
CNS
CNS
PRLB
PRLB
Q4 25
-3.45×
Q3 25
1.32×
4.03×
Q2 25
-1.84×
2.39×
Q1 25
-2.74×
5.11×
Q4 24
2.11×
Q3 24
0.65×
3.44×
Q2 24
0.99×
3.18×
Q1 24
0.14×
4.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

PRLB
PRLB

CNC Machining Firstcut$65.5M48%
Injection Molding Protomold$47.6M35%
Three D Printing Fineline$18.8M14%
Sheet Metal$4.4M3%

Related Comparisons